Novolog 100 unit/ML flexpen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3UTT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,096
Award facts
- Contract value 100% obligated
- $10,095.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,095.79 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with a completion date of February 2, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor on this award, operating as a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen). The company serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialty pharmaceuticals to support military healthcare programs worldwide. AmerisourceBergen's demonstrated capability to fulfill federal medical supply requirements through open competition, combined with its extensive portfolio spanning diabetes medications, neurological treatments, pain management products, and other therapeutic domains, positions the company as a significant vendor for government healthcare procurement.
Quick answers
Who was awarded contract SPE2DR26F3UTT?
SPE2DR26F3UTT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F3UTT worth?
The government has obligated $10,096 on SPE2DR26F3UTT.
Is contract SPE2DR26F3UTT an order under another contract?
Yes. SPE2DR26F3UTT is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3UTT competed?
The extent of competition for SPE2DR26F3UTT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award